ICYMI: JAKi in inflammatory myositis?

Save

Abstract 1731 is a small RCT of baricitinib in inflammatory myositis comparing early start baricitinib to later start.

Tocilizumab Efficacy in Giant Cell Arteritis Phenotypes

Save

Biosimilars Do Impact Biologic Drug Costs

Save

Introduction of biosimilars for the rheumatology drug adalimumab, whose original branded version Humira has long been a blockbuster, appears to have led to a dramatic drop in net spending for these products -- even though biosimilars barely dented Humira prescription rates.

ICYMI: Sex related differences in PsA

Save

Different factors are known to influence disease characteristics and outcomes in psoriatic arthritis (PsA).

ICYMI: Beyond the Needle: Redefining the Assessment of Lupus Nephritis

Save

Lupus nephritis is one of the most silent and severe manifestations of SLE. When not captured early, patients are at high risk of progressing to end-stage renal disease, which would require dialysis or transplantation. Renal biopsy remains the gold standard for diagnosis and disease classification. However, the procedure is invasive and very painful. Non-invasive measures are critical for early detection and continuous monitoring.

ICYMI: Are Emulation Trials a Fantasy?

Save

Are emulation ‘trials’ helpful, despite the biases that occur with observational data, or do they truly mimic the results of randomized controlled trials (RCTs)?